Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Quickcomparison

Dose Range Intermedin (Adrenomedullin-2) As prescribed–As prescribed mg Adrenomedullin Frequency Once daily Administration As directed by healthcare provider Intravenous infusion Cycle Length Ongoing/indefinite Onset Speed Moderate (1-2 weeks) Evidence Level L

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Dose Range
  • Intermedin (Adrenomedullin-2)
  • As prescribed–As prescribed mg
  • Adrenomedullin
  • Frequency
  • Once daily
  • Administration
  • As directed by healthcare provider
  • Intravenous infusion
  • Cycle Length
  • Ongoing/indefinite
  • Onset Speed
  • Moderate (1-2 weeks)
  • Evidence Level
  • Limited human trials
  • Moderate human trials (Phase 1-2)
  • Efficacy